Hum. Reprod. Advance Access published online on June 24, 2005
Human Reproduction, doi:10.1093/humrep/dei161
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Clinical Research Center of Women’s Health, Hindenburgdamm 30, D-12200 Berlin
* To whom correspondence should be addressed. BACKGROUND: In Germany, there is a lack of population-based data related to the use of gynaecological health care services. The objectives of our analyses utilizing a population-based cross-sectional survey conducted in one geographically defined area [Study of Health in Pomerania (SHIP)] are to assess the prevalences of: (i) attendance of gynaecological outpatient facilities and of (cervical) cancer screening; (ii) gynaecological and breast surgery; (iii) use of oral contraceptives (OC) and menopausal hormone therapy (MHT). METHODS: We analysed socio-demographic factors, reproductive history, gynaecological service utilization, and use of sex hormones in 2186 women aged 20-79 years. We used standard statistics and sex- and age group-specific weighting factors to reflect characteristics of the population of Western Pomerania. RESULTS: Approximately 43% of women reported surgical procedures. Participation in cancer screening at least once was reported by 78% of women (lifetime prevalence). Two-thirds of women stated ever use of OC, 28% (aged >40 years) ever use of MHT. CONCLUSIONS: Women in Western Pomerania reported a high life-time use of both OC and MHT. The use of cervical cancer screening exceeded the national average. Women had an almost 50% risk of undergoing gynaecological, breast or obstetric surgery. The high use of MHT and surgical procedures calls for efforts regarding continuing medical education and health care policy actions.
Received January 31, 2005
Revised May 23, 2005
Accepted May 27, 2005
Article
Gynaecological health care utilization and use of sex hormones-the study of Health in Pomerania
2 Ernst-Moritz-Arndt-University of Greifswald, Institute of Epidemiology and Social Medicine, Walther-Rathenau-Str. 48, D-17487 Greifswald
3 Ernst-Moritz-Arndt-University of Greifswald, Institute of Community Medicine, Section Epidemiology of Health Care and Community Health, Ellerholzstr. 1-2, D-17487 Greifswald, Germany
M. Dören, E-mail: martina.doeren{at}charite.de
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
N. Friedrich, R. Haring, M. Nauck, J. Ludemann, D. Rosskopf, E. Spilcke-Liss, S. B. Felix, M. Dorr, G. Brabant, H. Volzke, et al. Mortality and Serum Insulin-Like Growth Factor (IGF)-I and IGF Binding Protein 3 Concentrations J. Clin. Endocrinol. Metab., May 1, 2009; 94(5): 1732 - 1739. [Abstract] [Full Text] [PDF] |
||||
